ArticleTranslational pediatrics2025
Compound heterozygous low-density lipoprotein receptor variants causing homozygous of familial hypercholesterolemia in two sisters: a case report.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Familial hypercholesterolemia (FH) is a severe hereditary lipid metabolism disorder. Homozygous FH (HoFH) in particular was marked by rapid disease progression, with afflicted children at risk of developing coronary heart disease or even suffering from fatal myocardial infarction in their teenage years. This case report is aim to deepen understanding of HoFH's complexity and provide a scientific foundation for early diagnosis, personalized therapy to improve treatment protocols and reduce the burden on patients and families. Case Description: We report two Chinese sisters presenting with multiple xanthomas from early childhood. Laboratory results showed markedly elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels. Genetic testing revealed compound homozygous variants in the low-density lipoprotein receptor ( Conclusions: This study underscores the critical importance of early diagnosis and treatment in HoFH and highlights the necessity for ongoing research into more effective therapeutic strategies. Through this report, we aim to deepen the understanding of HoFH's complexity and foster the development of improved treatment protocols. Ultimately, our in-depth analysis aspires to provide a scientific foundation for early diagnosis, risk assessment, personalized therapy, and comprehensive management of FH, thereby alleviating the health burden imposed on affected patients and their families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.